Two elements favor the case for acquiring precision medicine stocks. First, the obvious point: barring extraordinary circumstances, the broader healthcare ecosystem will always be relevant. That is, humans will always try to find treatment solutions for various conditions and diseases. Second, the underlying sector will likely be a massive one based on expert projections.According to Precedence Research, the precision medicine market size reached a valuation of $73.49 billion in 2022. By 2030, the sector is ...